{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:02:50Z","timestamp":1790614970229,"version":"4.1.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s11154-022-09750-9","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T13:06:12Z","timestamp":1661173572000},"page":"1079-1087","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Cognitive deficits in primary hyperparathyroidism \u2013 what we know and what we do not know: A narrative review"],"prefix":"10.1007","volume":"23","author":[{"given":"Manju","family":"Chandran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia Tan Li","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mechteld C.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1570-2617","authenticated-orcid":false,"given":"John P.","family":"Bilezikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Parameswaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,22]]},"reference":[{"issue":"8","key":"9750_CR1","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00268-002-6621-0","volume":"26","author":"E Lundgren","year":"2002","unstructured":"Lundgren E, Hagstr\u00f6m EG, Lundin J, et al. Primary hyperparathyroidism revisited in menopausal women with serum calcium in the upper normal range at population-based screening 8 years ago. World J Surg. 2002;26(8):931\u20136.","journal-title":"World J Surg"},{"issue":"11","key":"9750_CR2","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1210\/jc.2018-01225","volume":"103","author":"JP Bilezikian","year":"2018","unstructured":"Bilezikian JP. Primary Hyperparathyroidism. J Clin Endocrinol Metab. 2018;103(11):3993\u20134004.","journal-title":"J Clin Endocrinol Metab"},{"key":"9750_CR3","doi-asserted-by":"crossref","unstructured":"Albright F, Reifenstein E Jr. The parathyroid glands and metabolic bone disease. selected studies. Fuller Albright, A.B., M.D., and Edward C. Reifenstein, Jr., A.B., M.D., F.A.C.P. Baltimore, The Williams and Wilkins Company, 1948. $8.00. JBJS 1949; 31(4).","DOI":"10.2106\/00004623-194931040-00029"},{"issue":"6","key":"9750_CR4","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.beem.2018.09.001","volume":"32","author":"S Minisola","year":"2018","unstructured":"Minisola S, Gianotti L, Bhadada S, Silverberg SJ. Classical complications of primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab. 2018;32(6):791\u2013803.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"6","key":"9750_CR5","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.beem.2018.06.006","volume":"32","author":"I Chiodini","year":"2018","unstructured":"Chiodini I, Cairoli E, Palmieri S, Pepe J, Walker MD. Non classical complications of primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab. 2018;32(6):805\u201320.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"9750_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1055\/s-0035-1555115","volume":"36","author":"DL Murman","year":"2015","unstructured":"Murman DL. The impact of age on cognition. Semin Hear. 2015;36(3):111\u201321.","journal-title":"Semin Hear"},{"key":"9750_CR7","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1146\/annurev-psych-120710-100328","volume":"63","author":"T Salthouse","year":"2012","unstructured":"Salthouse T. Consequences of age-related cognitive declines. Annu Rev Psychol. 2012;63:201\u201326.","journal-title":"Annu Rev Psychol"},{"issue":"5","key":"9750_CR8","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1097\/01.sla.0000186337.83407.ec","volume":"242","author":"LH Coker","year":"2005","unstructured":"Coker LH, Rorie K, Cantley L, et al. Primary hyperparathyroidism, cognition, and health-related quality of life. Ann Surg. 2005;242(5):642\u201350.","journal-title":"Ann Surg"},{"issue":"4","key":"9750_CR9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1177\/000313481307900419","volume":"79","author":"G Alex","year":"2013","unstructured":"Alex G, Morris L, Pasieka J, Perrier N. Nonclassical symptoms of primary hyperparathyroidism and their response to parathyroidectomy. Am Surg. 2013;79(4):337\u201343.","journal-title":"Am Surg"},{"key":"9750_CR10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.cell.2008.08.040","volume":"135","author":"J Regard","year":"2008","unstructured":"Regard J, Sato I, Coughlin S. Anatomical profiling of G protein-coupled receptor expression. Cell. 2008;135:561\u201371.","journal-title":"Cell"},{"issue":"2","key":"9750_CR11","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1124\/pr.114.009464","volume":"67","author":"TJ Gardella","year":"2015","unstructured":"Gardella TJ, J-P Vilardaga. International union of basic and clinical pharmacology. XCIII. The parathyroid hormone receptors-family B G protein-coupled receptors. Pharmacol Rev. 2015;67(2):310\u201337.","journal-title":"Pharmacol Rev"},{"issue":"3","key":"9750_CR12","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1677\/joe.1.06057","volume":"187","author":"JT Potts","year":"2005","unstructured":"Potts JT. Parathyroid hormone: past and present. J Endocrinol. 2005;187(3):311\u201325.","journal-title":"J Endocrinol"},{"issue":"3","key":"9750_CR13","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.bbrc.2004.11.069","volume":"328","author":"RC Gensure","year":"2005","unstructured":"Gensure RC, Gardella TJ, J\u00fcppner H. Parathyroid hormone and parathyroid hormone-related peptide, and their receptors. Biochem Biophys Res Commun. 2005;328(3):666\u201378.","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"9750_CR14","doi-asserted-by":"publisher","first-page":"5188","DOI":"10.1016\/S0021-9258(18)61172-X","volume":"262","author":"EF Nemeth","year":"1987","unstructured":"Nemeth EF, Scarpa A. Rapid mobilization of cellular Ca2+ in bovine parathyroid cells evoked by extracellular divalent cations. Evidence for a cell surface calcium receptor. J Biol Chem. 1987;262(11):5188\u201396.","journal-title":"J Biol Chem"},{"key":"9750_CR15","doi-asserted-by":"crossref","unstructured":"Conigrave AD. The calcium-sensing receptor and the parathyroid: past, present, future. Front Physiol. 2016;7.","DOI":"10.3389\/fphys.2016.00563"},{"issue":"1","key":"9750_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/10408360590886606","volume":"42","author":"J Tfelt-Hansen","year":"2005","unstructured":"Tfelt-Hansen J, Brown EM. The calcium-sensing receptor in normal physiology and pathophysiology: a review. Crit Rev Clin Lab Sci. 2005;42(1):35\u201370.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"5","key":"9750_CR17","first-page":"1075","volume":"56","author":"YH Chou","year":"1995","unstructured":"Chou YH, Pollak MR, Brandi ML, et al. Mutations in the human Ca(2+)-sensing-receptor gene that cause familial hypocalciuric hypercalcemia. Am J Hum Genet. 1995;56(5):1075\u20139.","journal-title":"Am J Hum Genet"},{"issue":"7","key":"9750_CR18","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/0092-8674(93)90617-Y","volume":"75","author":"MR Pollak","year":"1993","unstructured":"Pollak MR, Brown EM, Chou YH, et al. Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell. 1993;75(7):1297\u2013303.","journal-title":"Cell"},{"issue":"3","key":"9750_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/ng1194-303","volume":"8","author":"MR Pollak","year":"1994","unstructured":"Pollak MR, Brown EM, Estep HL, et al. Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation. Nat Genet. 1994;8(3):303\u20137.","journal-title":"Nat Genet"},{"issue":"1","key":"9750_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1042\/BST20110615","volume":"40","author":"CW Taylor","year":"2012","unstructured":"Taylor CW, Tovey SC. From parathyroid hormone to cytosolic Ca2+ signals. Biochem Soc Trans. 2012;40(1):147\u201352.","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"9750_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S1043-2760(02)00002-4","volume":"14","author":"TB Usdin","year":"2003","unstructured":"Usdin TB, Dobolyi A, Ueda H, Palkovits M. Emerging functions for tuberoinfundibular peptide of 39 residues. Trends Endocrinol Metab. 2003;14(1):14\u20139.","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"9750_CR22","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/0196-9781(93)90174-F","volume":"14","author":"S Harvey","year":"1993","unstructured":"Harvey S, Hayer S. Parathyroid hormone binding sites in the brain. Peptides. 1993;14(6):1187\u201391.","journal-title":"Peptides"},{"key":"9750_CR23","doi-asserted-by":"crossref","unstructured":"Dobolyi A, Dimitrov E, Palkovits M, Usdin TB. The neuroendocrine functions of the parathyroid hormone 2 receptor. Front Endocrinol (Lausanne). 2012;3:121-.","DOI":"10.3389\/fendo.2012.00121"},{"issue":"11","key":"9750_CR24","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/14724","volume":"2","author":"TB Usdin","year":"1999","unstructured":"Usdin TB, Hoare SR, Wang T, Mezey E, Kowalak JA. TIP39: a new neuropeptide and PTH2-receptor agonist from hypothalamus. Nat Neurosci. 1999;2(11):941\u20133.","journal-title":"Nat Neurosci"},{"issue":"3","key":"9750_CR25","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1073\/pnas.042416199","volume":"99","author":"A Dobolyi","year":"2002","unstructured":"Dobolyi A, Ueda H, Uchida H, Palkovits M, Usdin TB. Anatomical and physiological evidence for involvement of tuberoinfundibular peptide of 39 residues in nociception. Proc Natl Acad Sci U S A. 2002;99(3):1651\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"9750_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pneurobio.2009.10.017","volume":"90","author":"A Dobolyi","year":"2010","unstructured":"Dobolyi A, Palkovits M, Usdin TB. The TIP39-PTH2 receptor system: unique peptidergic cell groups in the brainstem and their interactions with central regulatory mechanisms. Prog Neurobiol. 2010;90(1):29\u201359.","journal-title":"Prog Neurobiol"},{"issue":"1","key":"9750_CR27","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1601-183X.2010.00643.x","volume":"10","author":"L Coutellier","year":"2011","unstructured":"Coutellier L, Logemann A, Kuo J, Rusnak M, Usdin TB. TIP39 modulates effects of novelty-induced arousal on memory. Genes Brain Behav. 2011;10(1):90\u20139.","journal-title":"Genes Brain Behav"},{"issue":"6","key":"9750_CR28","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1111\/jphp.13085","volume":"71","author":"G Venkatesh","year":"2019","unstructured":"Venkatesh G, Sankar V, Ramanathan M. Molecular mechanism of tuberoinfundibular peptide of 39 on glucocorticoid receptor mediated glutamate\/GABA imbalance and cerebral abnormalities against cognitive deficit model. J Pharm Pharmacol. 2019;71(6):996\u20131006.","journal-title":"J Pharm Pharmacol"},{"issue":"4","key":"9750_CR29","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/cne.21330","volume":"502","author":"CA Faber","year":"2007","unstructured":"Faber CA, Dobolyi A, Sleeman M, Usdin TB. Distribution of tuberoinfundibular peptide of 39 residues and its receptor, parathyroid hormone 2 receptor, in the mouse brain. J Comp Neurol. 2007;502(4):563\u201383.","journal-title":"J Comp Neurol"},{"issue":"2","key":"9750_CR30","first-page":"51","volume":"37","author":"ER de Kloet","year":"2003","unstructured":"de Kloet ER. Hormones, brain and stress. Endocr Regul. 2003;37(2):51\u201368.","journal-title":"Endocr Regul"},{"key":"9750_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/806104","volume":"2013","author":"K Alkadhi","year":"2013","unstructured":"Alkadhi K. Brain Physiology and Pathophysiology in Mental Stress. ISRN Physiology. 2013;2013: 806104.","journal-title":"ISRN Physiology"},{"issue":"14","key":"9750_CR32","doi-asserted-by":"publisher","first-page":"5801","DOI":"10.1073\/pnas.1019128108","volume":"108","author":"MJ Henckens","year":"2011","unstructured":"Henckens MJ, van Wingen GA, Jo\u00ebls M, Fern\u00e1ndez G. Time-dependent corticosteroid modulation of prefrontal working memory processing. Proc Natl Acad Sci U S A. 2011;108(14):5801\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"9750_CR33","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2174\/1573407213666170905155415","volume":"14","author":"S Veintramuthu","year":"2018","unstructured":"Veintramuthu S, Gunasekaran V, Ramanathan M, Selvaraj D. Tuberoinfundibular peptide of 39 attenuates chronic unpredictable mild stress induced HPA axis dysregulation, inflammation and oxidative damage in depressive rats. Curr Bioact Compd. 2018;14(4):451\u201360.","journal-title":"Curr Bioact Compd"},{"key":"9750_CR34","first-page":"1","volume":"11","author":"V Gunasekaran","year":"2017","unstructured":"Gunasekaran V, Mathew MM, Gautam M, Ramanathan M. Neuroprotective role of Pterocarpus marsupium Roxb in streptozotocin-induced diabetic neuropathic pain in Type 2 diabetic rats. J Pharm Res. 2017;11:1\u20137.","journal-title":"J Pharm Res"},{"issue":"26","key":"9750_CR35","doi-asserted-by":"publisher","first-page":"15455","DOI":"10.1074\/jbc.270.26.15455","volume":"270","author":"TB Usdin","year":"1995","unstructured":"Usdin TB, Gruber C, Bonner TI. Identification and functional expression of a receptor selectively recognizing parathyroid hormone, the PTH2 receptor. J Biol Chem. 1995;270(26):15455\u20138.","journal-title":"J Biol Chem"},{"issue":"2","key":"9750_CR36","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ceca.2009.11.013","volume":"47","author":"EC Toescu","year":"2010","unstructured":"Toescu EC, Vreugdenhil M. Calcium and normal brain ageing. Cell Calcium. 2010;47(2):158\u201364.","journal-title":"Cell Calcium"},{"issue":"4","key":"9750_CR37","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00234-006-0198-5","volume":"49","author":"TF Cermik","year":"2007","unstructured":"Cermik TF, Kaya M, U\u011fur-Altun B, Bedel D, Berkarda S, Yi\u011fitba\u015fi ON. Regional cerebral blood flow abnormalities in patients with primary hyperparathyroidism. Neuroradiology. 2007;49(4):379\u201385.","journal-title":"Neuroradiology"},{"issue":"10","key":"9750_CR38","doi-asserted-by":"publisher","first-page":"3849","DOI":"10.1210\/jc.2009-1086","volume":"94","author":"MD Walker","year":"2009","unstructured":"Walker MD, Fleischer J, Rundek T, et al. Carotid vascular abnormalities in primary hyperparathyroidism. J Clin Endocrinol Metab. 2009;94(10):3849\u201356.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"9750_CR39","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/BF02447647","volume":"122","author":"DN Khudaverdyan","year":"1996","unstructured":"Khudaverdyan DN, Asratyan AA. Effect of the parathyroid hormone\u2014Calcium system on functional activity of the hypothalamus-neurohypophysis complex. Bull Exp Biol Med. 1996;122(5):1069\u201371.","journal-title":"Bull Exp Biol Med"},{"issue":"21","key":"9750_CR40","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1056\/NEJM196605262742105","volume":"274","author":"O Cope","year":"1966","unstructured":"Cope O. The story of hyperparathyroidism at the Massachusetts General Hospital. N Engl J Med. 1966;274(21):1174\u201382.","journal-title":"N Engl J Med"},{"issue":"16","key":"9750_CR41","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1001\/jama.1934.02750160010003","volume":"102","author":"F Albright","year":"1934","unstructured":"Albright F, Aub JC, Bauer W. Hyperparathyroidism: a common and polymorphic condition as illustrated by seventeen proved cases from one clinic. J Am Med Assoc. 1934;102(16):1276\u201387.","journal-title":"J Am Med Assoc"},{"key":"9750_CR42","first-page":"N117","volume":"17","author":"SJ Silverberg","year":"2002","unstructured":"Silverberg SJ. Non-classical target organs in primary hyperparathyroidism. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research. 2002;17:N117\u201325.","journal-title":"Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research"},{"issue":"2","key":"9750_CR43","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1210\/jc.2008-1760","volume":"94","author":"SJ Silverberg","year":"2009","unstructured":"Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab. 2009;94(2):351\u201365.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"9750_CR44","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","volume":"151","author":"SM Wilhelm","year":"2016","unstructured":"Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016;151(10):959\u201368.","journal-title":"JAMA Surg"},{"key":"9750_CR45","doi-asserted-by":"publisher","first-page":"1095414","DOI":"10.1155\/2020\/1095414","volume":"2020","author":"C Voci","year":"2020","unstructured":"Voci C. Dementia Improvement after Primary Hyperparathyroidism Surgery. Case Rep Med. 2020;2020:1095414.","journal-title":"Case Rep Med"},{"issue":"1","key":"9750_CR46","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1365-2265.2004.02180.x","volume":"62","author":"CY Chiang","year":"2005","unstructured":"Chiang CY, Andrewes DG, Anderson D, Devere M, Schweitzer I, Zajac JD. A controlled, prospective study of neuropsychological outcomes post parathyroidectomy in primary hyperparathyroid patients. Clin Endocrinol (Oxf). 2005;62(1):99\u2013104.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9750_CR47","doi-asserted-by":"crossref","unstructured":"Roman SA, Sosa JA, Mayes L, et al. Parathyroidectomy improves neurocognitive deficits in patients with primary hyperparathyroidism. Surgery. 2005;138(6):1121\u20138; discussion 8\u20139","DOI":"10.1016\/j.surg.2005.08.033"},{"issue":"6","key":"9750_CR48","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1017\/S1355617709990695","volume":"15","author":"JF Benge","year":"2009","unstructured":"Benge JF, Perrier ND, Massman PJ, Meyers CA, Kayl AE, Wefel JS. Cognitive and affective sequelae of primary hyperparathyroidism and early response to parathyroidectomy. J Int Neuropsychol Soc. 2009;15(6):1002\u201311.","journal-title":"J Int Neuropsychol Soc"},{"issue":"6","key":"9750_CR49","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.surg.2009.09.034","volume":"146","author":"ND Perrier","year":"2009","unstructured":"Perrier ND, Balachandran D, Wefel JS, et al. Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with \u201casymptomatic\u201d primary hyperparathyroidism. Surgery. 2009;146(6):1116\u201322.","journal-title":"Surgery"},{"issue":"5","key":"9750_CR50","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1007\/s00268-005-0444-8","volume":"30","author":"CM Dotzenrath","year":"2006","unstructured":"Dotzenrath CM, Kaetsch AK, Pfingsten H, et al. Neuropsychiatric and cognitive changes after surgery for primary hyperparathyroidism. World J Surg. 2006;30(5):680\u20135.","journal-title":"World J Surg"},{"issue":"6","key":"9750_CR51","first-page":"1119","volume":"96","author":"P Numann","year":"1984","unstructured":"Numann P, Torppa A, Blumetti A. Neuropsychologic deficits associated with primary hyperparathyroidism. Surgery. 1984;96(6):1119\u201323.","journal-title":"Surgery"},{"issue":"5","key":"9750_CR52","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00423-011-0885-5","volume":"397","author":"D Babi\u0144ska","year":"2012","unstructured":"Babi\u0144ska D, Barczy\u0144ski M, Stefaniak T, et al. Evaluation of selected cognitive functions before and after surgery for primary hyperparathyroidism. Langenbecks Arch Surg. 2012;397(5):825\u201331.","journal-title":"Langenbecks Arch Surg"},{"key":"9750_CR53","unstructured":"Casella C, Pata G, Di Betta E, Nascimbeni R. Neurological and psychiatric disorders in primary hyperparathyroidism: the role of parathyroidectomy. Annali Italiani Di Chirurgia 2008;79(3):157\u201361; discussion 61."},{"issue":"4","key":"9750_CR54","doi-asserted-by":"publisher","first-page":"338","DOI":"10.4158\/EP.13.4.338","volume":"13","author":"EA Mittendorf","year":"2007","unstructured":"Mittendorf EA, Wefel JS, Meyers CA, et al. Improvement of sleep disturbance and neurocognitive function after parathyroidectomy in patients with primary hyperparathyroidism. Endocr Pract. 2007;13(4):338\u201344.","journal-title":"Endocr Pract"},{"issue":"6","key":"9750_CR55","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1067\/msy.2002.128606","volume":"132","author":"G Prager","year":"2002","unstructured":"Prager G, Kalaschek A, Kaczirek K, et al. Parathyroidectomy improves concentration and retentiveness in patients with primary hyperparathyroidism. Surgery. 2002;132(6):930\u20136.","journal-title":"Surgery"},{"issue":"1","key":"9750_CR56","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/SLA.0b013e3181f66720","volume":"253","author":"SA Roman","year":"2011","unstructured":"Roman SA, Sosa JA, Pietrzak RH, et al. The effects of serum calcium and parathyroid hormone changes on psychological and cognitive function in patients undergoing parathyroidectomy for primary hyperparathyroidism. Ann Surg. 2011;253(1):131\u20137.","journal-title":"Ann Surg"},{"issue":"6","key":"9750_CR57","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1210\/jc.2008-2574","volume":"94","author":"MD Walker","year":"2009","unstructured":"Walker MD, McMahon DJ, Inabnet WB, et al. Neuropsychological features in primary hyperparathyroidism: a prospective study. J Clin Endocrinol Metab. 2009;94(6):1951\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"9750_CR58","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/0002-9343(78)90748-9","volume":"65","author":"MG Cogan","year":"1978","unstructured":"Cogan MG, Covey CM, Arieff AI, et al. Central nervous system manifestations of hyperparathyroidism. Am J Med. 1978;65(6):963\u201370.","journal-title":"Am J Med"},{"issue":"12","key":"9750_CR59","first-page":"677","volume":"55","author":"A Goyal","year":"2001","unstructured":"Goyal A, Chumber S, Tandon N, Lal R, Srivastava A, Gupta S. Neuropsychiatric manifestations in patients of primary hyperparathyroidism and outcome following surgery. Indian J Med Sci. 2001;55(12):677\u201386.","journal-title":"Indian J Med Sci"},{"issue":"3","key":"9750_CR60","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s40618-019-01128-0","volume":"43","author":"M Liu","year":"2020","unstructured":"Liu M, Sum M, Cong E, et al. Cognition and cerebrovascular function in primary hyperparathyroidism before and after parathyroidectomy. J Endocrinol Invest. 2020;43(3):369\u201379.","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"9750_CR61","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.surg.2015.03.054","volume":"158","author":"K Zanocco","year":"2015","unstructured":"Zanocco K, Butt Z, Kaltman D, et al. Improvement in patient-reported physical and mental health after parathyroidectomy for primary hyperparathyroidism. Surgery. 2015;158(3):837\u201345.","journal-title":"Surgery"},{"issue":"5","key":"9750_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127574","volume":"10","author":"I Lourida","year":"2015","unstructured":"Lourida I, Thompson-Coon J, Dickens CM, et al. Parathyroid hormone, cognitive function and dementia: a systematic review. PLoS ONE. 2015;10(5): e0127574.","journal-title":"PLoS ONE"},{"issue":"1","key":"9750_CR63","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jbmr.4199","volume":"36","author":"M Pretorius","year":"2021","unstructured":"Pretorius M, Lundstam K, Hellstr\u00f6m M, et al. Effects of parathyroidectomy on quality of life: 10 years of data from a prospective randomized controlled trial on primary hyperparathyroidism (the SIPH-Study). J Bone Miner Res. 2021;36(1):3\u201311.","journal-title":"J Bone Miner Res"},{"key":"9750_CR64","doi-asserted-by":"crossref","unstructured":"Sheldon DG, Lee FT, Neil NJ, Ryan JA Jr. Surgical treatment of hyperparathyroidism improves health-related quality of life. Arch Surg.\u00a02002;137(9):1022\u20136; discussion 6\u20138.","DOI":"10.1001\/archsurg.137.9.1022"},{"key":"9750_CR65","doi-asserted-by":"crossref","unstructured":"Caillard C, Sebag F, Mathonnet M, et al. Prospective evaluation of quality of life (SF-36v2) and nonspecific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up). Surgery. 2007;141(2):153\u20139; discussion 9\u201360.","DOI":"10.1016\/j.surg.2006.12.004"},{"issue":"8","key":"9750_CR66","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1210\/jc.2007-0219","volume":"92","author":"E Ambrogini","year":"2007","unstructured":"Ambrogini E, Cetani F, Cianferotti L, et al. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab. 2007;92(8):3114\u201321.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"9750_CR67","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00268-008-9509-9","volume":"32","author":"R Mihai","year":"2008","unstructured":"Mihai R, Sadler GP. Pasieka\u2019s parathyroid symptoms scores correlate with SF-36 scores in patients undergoing surgery for primary hyperparathyroidism. World J Surg. 2008;32(5):807\u201314.","journal-title":"World J Surg"},{"issue":"5","key":"9750_CR68","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1210\/jc.2006-1836","volume":"92","author":"J Bollerslev","year":"2007","unstructured":"Bollerslev J, Jansson S, Mollerup CL, et al. Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab. 2007;92(5):1687\u201392.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"9750_CR69","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0002-9629(15)40527-0","volume":"317","author":"KV Kowdley","year":"1999","unstructured":"Kowdley KV, Coull BM, Orwoll ES. Cognitive impairment and intracranial calcification in chronic hypoparathyroidism. Am J Med Sci. 1999;317(5):273\u20137.","journal-title":"Am J Med Sci"},{"issue":"2","key":"9750_CR70","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/NRL.0b013e31815b0de2","volume":"14","author":"RM Bonelli","year":"2008","unstructured":"Bonelli RM, Cummings JL. Frontal-subcortical dementias. Neurologist. 2008;14(2):100\u20137.","journal-title":"Neurologist"},{"issue":"1","key":"9750_CR71","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/gerona\/glq185","volume":"66","author":"DJ Llewellyn","year":"2011","unstructured":"Llewellyn DJ, Lang IA, Langa KM, Melzer D. Vitamin D and cognitive impairment in the elderly U.S. population. J Gerontol A Biol Sci Med Sci. 2011;66(1):59\u201365.","journal-title":"J Gerontol A Biol Sci Med Sci."},{"key":"9750_CR72","doi-asserted-by":"crossref","unstructured":"Giustina A, Bouillon R, Binkley N, et al. Controversies in Vitamin D: A statement from the third international conference. JBMR Plus. 2020;4(12):e10417-n\/a.","DOI":"10.1002\/jbm4.10417"},{"issue":"7","key":"9750_CR73","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/jamaneurol.2014.755","volume":"71","author":"ED Michos","year":"2014","unstructured":"Michos ED, Carson KA, Schneider AL, et al. Vitamin D and subclinical cerebrovascular disease: the Atherosclerosis Risk in Communities brain magnetic resonance imaging study. JAMA Neurol. 2014;71(7):863\u201371.","journal-title":"JAMA Neurol"},{"issue":"1","key":"9750_CR74","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/cen.12733","volume":"83","author":"JH Moon","year":"2015","unstructured":"Moon JH, Lim S, Han JW, et al. Serum 25-hydroxyvitamin D level and the risk of mild cognitive impairment and dementia: the Korean Longitudinal Study on Health and Aging (KLoSHA). Clin Endocrinol (Oxf). 2015;83(1):36\u201342.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"9750_CR75","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3233\/JAD-2009-1024","volume":"17","author":"WB Grant","year":"2009","unstructured":"Grant WB. Does vitamin D reduce the risk of dementia? J Alzheimers Dis. 2009;17(1):151\u20139.","journal-title":"J Alzheimers Dis"},{"issue":"Suppl 2","key":"9750_CR76","doi-asserted-by":"publisher","first-page":"V100","DOI":"10.1359\/jbmr.07s202","volume":"22","author":"SJ Silverberg","year":"2007","unstructured":"Silverberg SJ. Vitamin D deficiency and primary hyperparathyroidism. J Bone Miner Res. 2007;22(Suppl 2):V100\u20134.","journal-title":"J Bone Miner Res"},{"key":"9750_CR77","doi-asserted-by":"crossref","unstructured":"Crosson B, Ford A, McGregor KM, et al. Functional imaging and related techniques: an introduction for rehabilitation researchers. J Rehabil Res Dev. 2010;47(2):vii-xxxiv.","DOI":"10.1682\/JRRD.2010.02.0017"},{"issue":"1","key":"9750_CR78","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1530\/EJE-20-0123","volume":"183","author":"Y Gazes","year":"2020","unstructured":"Gazes Y, Liu M, Sum M, et al. Functional magnetic resonance imaging in primary hyperparathyroidism. Eur J Endocrinol. 2020;183(1):21\u201330.","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"9750_CR79","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s00268-005-0361-x","volume":"30","author":"ND Perrier","year":"2006","unstructured":"Perrier ND, Coker LH, Rorie KD, et al. Preliminary report: functional MRI of the brain may be the ideal tool for evaluating neuropsychologic and sleep complaints of patients with primary hyperparathyroidism. World J Surg. 2006;30(5):686\u201396.","journal-title":"World J Surg"},{"issue":"4","key":"9750_CR80","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00234-006-0198-5","volume":"49","author":"TF \u00c7ermik","year":"2007","unstructured":"\u00c7ermik TF, Kaya M, U\u011fur-Altun B, Bedel D, Berkarda \u015e, Yi\u011fitba\u015f\u0131 \u00d6N. Regional cerebral blood flow abnormalities in patients with primary hyperparathyroidism. Neuroradiology. 2007;49(4):379\u201385.","journal-title":"Neuroradiology"},{"issue":"14","key":"9750_CR81","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.1523\/JNEUROSCI.1864-17.2018","volume":"38","author":"P Kundu","year":"2018","unstructured":"Kundu P, Benson BE, Rosen D, et al. The integration of functional brain activity from adolescence to adulthood. J Neurosci. 2018;38(14):3559\u201370.","journal-title":"J Neurosci"},{"key":"9750_CR82","doi-asserted-by":"crossref","unstructured":"Chen SHA, Wu C-Y, Lua R-p, Akoshi MM, Nakai T. Age-related changes in resting-state and task-activated functional MRI networks. IEEE.\u00a02013;218\u201322.","DOI":"10.1109\/ISMICT.2013.6521732"},{"issue":"6","key":"9750_CR83","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s11682-019-00184-7","volume":"14","author":"Y Lou","year":"2019","unstructured":"Lou Y, Zhao L, Yu S, et al. Brain asymmetry differences between Chinese and Caucasian populations: a surface-based morphometric comparison study. Brain Imaging Behav. 2019;14(6):2323\u201332.","journal-title":"Brain Imaging Behav"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-022-09750-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-022-09750-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-022-09750-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T05:17:41Z","timestamp":1664255861000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-022-09750-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":83,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["9750"],"URL":"https:\/\/doi.org\/10.1007\/s11154-022-09750-9","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,22]]},"assertion":[{"value":"4 August 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The article complied with all ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None of the authors have any conflicts of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}